Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Cheung
    Cheung
  8. Voss
    Voss
  9. O'Reilly
    O'Reilly
  10. Robson
    Robson

Groups

  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)
  7. Epidemiology and Biostatistics (151)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (121)
  10. Surgery (118)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Roberta Zappasodi (24)

More People

Years
  1. 2025 (28)
  2. 2024 (63)
  3. 2023 (45)
  4. 2022 (123)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (404)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (46)
  5. Journal of Hematology & Oncology (42)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
    Journal Article

    Gao, C.; Xiao, G.; Piersigilli, A.; Gou, J.; Ogunwobi, O.; Bargonetti, J.
    Breast Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical trial experience with CA4P anticancer therapy: Focus on efficacy, cardiovascular adverse events, and hypertension management
    Review

    Grisham, R.; Ky, B.; Tewari, K. S.; Chaplin, D. J.; Walker, J.
    Gynecologic Oncology Research and Practice (2018)

    Fulltext@MSK | Save
  • Design considerations for early-phase clinical trials of immune-oncology agents
    Journal Article

    Wages, N. A.; Chiuzan, C.; Panageas, K. S.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • The first clinical/translational data from the expansion cohorts of a Ph1/1b study of IPI-549, a tumor macrophage-reprogramming small molecule, in combination with nivolumab in advanced solid tumors
    Meeting Abstract

    Chmielowski, B.; Sullivan, R. J.; Postow, M.; Patnaik, A.; Shapiro, G.; Cohen, E.; Gutierrez, M.; Steuer, C.; Ribas, A.; Lee, L.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project
    Meeting Abstract

    Fabrizio, D.; Chen, S. J.; Xie, M.; Chen, W.; Quin, K. J.; Zhao, C.; Zehir, A.; Funari, V.; Dickey, J. S.; Gupta, V.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Peripheral T cell dynamics in resectable NSCLC patients treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; El Asmar, M.; Caushi, J.; Anagnostou, V.; Chan, H. Y.; Suri, P.; Guo, H.; Marrone, K.; Naidoo, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Refractory renal cell cancer (RCC) exhibits high adenosine A2A receptor (A2AR) expression and prolonged survival following treatment with the A2AR antagonist, CPI-444
    Meeting Abstract

    Fong, L.; Fong, L.; Powderly, J.; Luke, J.; Hotson, D.; Sznol, M.; George, S.; Choueiri, T.; Rini, B.; Hellmann, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Phase 1 study using mogamulizumab (KW-0761) to deplete regulatory T cells in combination with checkpoint inhibitors durvalumab (MEDI4736) or tremelimumab in subjects with advanced solid tumors
    Meeting Abstract

    Zamarin, D.; Hamid, O.; Nayak, A.; Sahebjam, S.; Sznol, M.; Collaku, A.; Fox, F.; Marshall, M.; Hong, D.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Preliminary clinical data from a pilot study of NY-ESO-1c259T-cells in advanced myxoid/round cell liposarcoma
    Meeting Abstract

    D'Angelo, S.; Stadanlick, J.; Druta, M.; Liebner, D.; Schuetze, S.; Van Tine, B.; Tap, W.; Britten, C.; Chagin, K.; Hasan, A.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save